Clinical Trials

Patients are eligible to be included in the study only if they meet all of the required criteria

List of Clinical Trial Opportunities

THERAPEUTIC AREA SPONSOR STATUS ACTION
A COVID-19 Vaccine
A COVID-19 vaccine study for people who have received kidney or liver transplants		 Active Get Started
Hodgkin Disease
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)		 Active Get Started
Respiratory Syncytial Virus
A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults Aged 18 to 49 Years and in Children Aged 12 to 36 Months Who Are Respiratory Syncytial Virus Seropositive		 Active Get Started
Metastatic Colorectal Adenocarcinoma
Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer		 Active Get Started
Schizophrenia
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia		 Active Get Started
Neurobehavioral Disinhibition
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury		 Active Get Started
Cytomegalovirus Infection
Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults		 Active Get Started
Rheumatoid Arthritis
Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA		 Upcoming
SARS-CoV-2
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19		 Completed
SARS-CoV Infection, Covid19
A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2		 Completed
Melanoma
An Efficacy Study of Adjuvant Treatment with a Personalized mRNA Cancer Vaccine and Pembrolizumab in Melanoma Patients at High Risk of Cancer Recurrence		 Completed
SARS-CoV-2
A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19		 Completed
Solution

Our features

We want to empower you to securely access, store, track, and exchange your health data with your chosen medical professional.
Technology

Our technology

Patientory is designed to eliminate many of the pain points in the current healthcare environments, which can adapt to changing trends in Healthcare management.
Technology

About us

We connect doctors, care providers, and consumers all within a single, secure platform – creating a care team that works together to provide the best care.
Get started organizing your health
Download Patientory App Request App Code